Carregant...

FFS: an end(point) to our problems in chronic GVHD trials?

In this issue of Blood, Inamoto et al provide encouragement that we are reaching the time where we have a robust endpoint to use in large, randomized clinical trials testing novel agents in chronic graft-versus-host disease (GVHD).(1)

Guardat en:
Dades bibliogràfiques
Autor principal: Jacobsohn, David A.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2014
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4141511/
https://ncbi.nlm.nih.gov/pubmed/25147381
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2014-06-579672
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!